SUPREMO, an MRC Phase 111 randomised trial to assess the role of adjuvant chest wall irradiation in ‘intermediate risk’ operable breast cancer following mastectomy

Hdl Handle:
http://hdl.handle.net/10147/198679
Title:
SUPREMO, an MRC Phase 111 randomised trial to assess the role of adjuvant chest wall irradiation in ‘intermediate risk’ operable breast cancer following mastectomy
Issue Date:
22-Dec-2011
URI:
http://hdl.handle.net/10147/198679
Keywords:
BREAST CANCER; MASTECTOMY
Research Methodology:
Site: Whitfield Private Clinic, Waterford
Ethical Approval:
Yes
Start Date:
2009-07
Principal Investigator:
Sasiadek, Wojciech Dr.

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-12-22T12:18:40Z-
dc.date.available2011-12-22T12:18:40Z-
dc.date.issued2011-12-22T12:18:40Z-
dc.identifier.urihttp://hdl.handle.net/10147/198679-
dc.subjectBREAST CANCERen
dc.subjectMASTECTOMYen
dc.titleSUPREMO, an MRC Phase 111 randomised trial to assess the role of adjuvant chest wall irradiation in ‘intermediate risk’ operable breast cancer following mastectomyen
dc.type.qualificationlevelN/Aen
cr.methodologySite: Whitfield Private Clinic, Waterforden
cr.approval.ethicalYesen
cr.contributor.principalSasiadek, Wojciech Dr.en
cr.date.start2009-07-
dc.description.provinceMunster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.